Tyra Lagerberg
Biographic Data
| ID | 7373988 |
|---|---|
| NAME | Tyra Lagerberg |
| GIVEN NAMES | Tyra |
| FAMILY NAME | Lagerberg |
| SIGNATURE | LAGERBERG T |
| AFFILIATIONS | Karolinska Institutet |
| ORCID | 0000-0003-2480-0216 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Melatonin use and the risk of self‐harm and unintentional injuries in youths with and without psychiatric disorders
BACKGROUND: Sleep disorders in youth have been associated with increased risks of injury, including suicidal behavior. This study investigated whether melatonin, which is the most common medication for sleep disturbances in youth in Sweden, is associated with a decreased risk of injury. METHODS: This population-based cohort study included 25,575 youths who initiated melatonin treatment between ages 6 and 18. Poisson regression was used to estimat…
Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment
Several of the detected signals for reduced risk correspond to drugs where there is previous evidence of benefit for antidepressant augmentation (e.g., olanzapine, quetiapine, lithium, buspirone, and mirtazapine). Novel signals of reduced suicidal behavior risk, including for lamotrigine, valproic acid, risperidone, and melatonin, warrant further investigation
No prominent works on this page.
Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment
Several of the detected signals for reduced risk correspond to drugs where there is previous evidence of benefit for antidepressant augmentation (e.g., olanzapine, quetiapine, lithium, buspirone, and mirtazapine). Novel signals of reduced suicidal behavior risk, including for lamotrigine, valproic acid, risperidone, and melatonin, warrant further investigation
Melatonin use and the risk of self‐harm and unintentional injuries in youths with and without psychiatric disorders
BACKGROUND: Sleep disorders in youth have been associated with increased risks of injury, including suicidal behavior. This study investigated whether melatonin, which is the most common medication for sleep disturbances in youth in Sweden, is associated with a decreased risk of injury. METHODS: This population-based cohort study included 25,575 youths who initiated melatonin treatment between ages 6 and 18. Poisson regression was used to estimat…
Anxiety (2 works) · Confidence interval (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Psychiatry (2 works) · Alprazolam (1 work) · Antidepressant (1 work) · Bipolar Disorder and Treatment (1 work) · Circadian rhythm and melatonin (1 work) · Cohort (1 work)